Human Immunodeficiency Virus (HIV) Infection
Immunology·MeSH: Acquired Immunodeficiency Syndrome
4 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Doravirine | Merck & Co., Inc. (MRK) |
Phase 2(2)
Phase 1(1)
| Drug | Company |
|---|---|
| hb-502 | HOOKIPA Pharma Inc. (HOOK) |
Compare drugs
Frequently asked questions
How many drugs are in development for Human Immunodeficiency Virus (HIV) Infection?
BioSniper tracks 4 drugs in development for Human Immunodeficiency Virus (HIV) Infection across 2 companies.
How many clinical trials target Human Immunodeficiency Virus (HIV) Infection?
There are 4 clinical trials targeting Human Immunodeficiency Virus (HIV) Infection tracked by BioSniper.
Deep-dive into Human Immunodeficiency Virus (HIV) Infection
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis